The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

By Kiper Ahmet   Yiğitbası Orhan   Imamoglu Abdurrahim   Tuygun Can   Turan Celaleddin  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 571-576

Springer Publishing Company

Access to resources Recommend Favorite

Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review 2

By Schmitt B.   Wilt T.J.   Schellhammer P.F.   DeMasi V.   Sartor O.   Crawford E.D.   Bennett C.L.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 727-732

Elsevier

Access to resources Recommend Favorite

Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?

By Labrie F.   Candas B.   Gomez J.-L.   Cusan L.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Pilot attempt of advanced prostate cancer treatment T3NxMx−1 by intermittent more complete androgen blockade

By Dutkiewicz Slawomir  

International Urology and Nephrology, Vol. 36, Iss. 3, 2004-09 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite

A Longer Duration of Neo-Adjuvant Combined Androgen Blockade Prior to Radical Prostatectomy May Lead to Lower Tumour Volume of Localised Prostate Cancer

By Lorente J.A.   Arango O.   Bielsa O.   Cortadellas R.   Lloreta-Trull J.   Gelabert-Mas A.  

European Urology, Vol. 43, Iss. 2, 2003-02 ,pp. : 119-123

Elsevier

Access to resources Recommend Favorite